Our Firm has filed a number of Biomet hip replacement lawsuits in this proceeding, and are pleased with its progress thus far.
New York, New York (PRWEB) October 11, 2013
Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) continue to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to an Order dated October 9, 2013, the Court is considering the appointment of a special discovery master and the issuance of a scheduling order. Among other things, the Order directs Plaintiffs’ attorneys to submit a proposed form of order that would appoint a special master and establish a scheduling order covering events to the point of trial readiness of the first bellwether trial by October 25, 2013. Attorneys for Biomet have been directed to file any objections to the plaintiffs’ proposal by November 1, 2013. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“Our Firm has filed a number of Biomet hip replacement lawsuits in this proceeding, and are pleased with its progress thus far,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by this Biomet M2a Magnum hip.
Biomet Hip Replacement Allegations
According to court records, all of the Biomet hip replacement lawsuits pending in the Northern District of Indiana involve the Biomet M2a Magnum Hip Replacement System. Plaintiffs allege that its metal-on-metal design, which consists of a ball and cup made from a chromium cobalt alloy, can cause the hip to shed dangerous amounts of metal debris leading to serious and debilitating complications, premature failure of the device, and revision surgery to remove and replace the implant. Court documents indicate that more than 650 Biomet hip lawsuits are currently pending in the federal litigations.
In January 2013, the U.S. Food & Drug Administration (FDA) issued an advisory on metal-on-metal hip replacements, warning that they had been associated with higher rates of early failure compared to those made from other materials. The FDA has advised recipients of all-metal hips to undergo metal ion blood testing if they experience any symptoms that would indicate their device could be failing. The agency has also proposed new regulations that would subject such implants to more regulatory oversight.
Victims of serious complications allegedly associated with the Biomet M2a Magnum hip may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about the litigation involving Biomet hip replacements and other metal-on-metal hips at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP